Awaiting product image

Hbv Drug Resistance (Lamivudine, Telbivudine, Adefovir, Tenofovir And Entecavir)

₹6,000.00

15 minutes
Categories: ,

The HBV Drug Resistance Test is a diagnostic test used to identify mutations in the Hepatitis B virus (HBV) that may make it resistant to specific antiviral drugs. This test focuses on detecting genetic variations in the HBV DNA that could render certain medications ineffective in controlling the infection. The test is essential for understanding how the virus responds to different treatments and is primarily used when patients show signs of treatment failure or drug resistance.
The test is typically used to assess resistance to the following antiviral medications:
1. Lamivudine
2. Telbivudine
3. Adefovir
4. Tenofovir
5. Entecavir
By identifying specific mutations in the HBV genome, the test helps doctors make informed decisions about changing or adjusting antiviral therapies.

Enquiry Here

    Description

    Why It’s Done

    The HBV Drug Resistance Test is conducted for several important reasons:
    1. Monitor Treatment Effectiveness: Over time, the HBV virus can develop resistance to antiviral drugs, especially if treatment is not consistent or if the virus is exposed to suboptimal drug levels. This test helps detect such resistance, guiding clinicians to alter treatment plans if necessary.
    2. Identify Drug-Resistant Strains: The test identifies specific mutations in the HBV genome associated with resistance to drugs like lamivudine, adefovir, telbivudine, tenofovir, and entecavir. Detecting these mutations allows healthcare providers to avoid using drugs that may no longer be effective.
    3. Optimize Treatment Choices: If resistance is detected, the test helps healthcare providers choose the most appropriate alternative therapies. This ensures that treatment is effective in controlling the viral load and preventing liver damage.
    4. Avoid Treatment Failure: Drug resistance can lead to treatment failure, where the virus continues to replicate despite antiviral therapy. The test allows for early detection, helping prevent this outcome and preserving liver health.
    5. Guide Long-Term Management: For individuals with chronic HBV, the drug resistance test is important for adjusting treatment over time to ensure sustained viral suppression and prevent complications like cirrhosis or liver cancer.
    6. Personalized Therapy: The test allows for a more personalized approach to treating HBV, ensuring that patients receive drugs that are most likely to be effective for their specific strain of the virus.

    Preparation for the HBV Drug Resistance Test
    1. Inform Your Doctor About Current Medications: It’s essential to provide your doctor with a list of all antiviral medications you are currently taking, including the dosage and frequency. This information helps ensure that the test results are interpreted correctly, especially in relation to any ongoing treatment.
    2. Avoid New Medications or Changes in Dosage Before the Test: If possible, avoid starting or changing any medications, including HBV treatments, right before the test, unless advised by your healthcare provider. This is to ensure that the test results accurately reflect your current treatment and viral load.
    3. No Fasting Required: Typically, there is no need to fast before the HBV drug resistance test, but this may vary depending on the specific test protocol or if other tests are being conducted along with it.
    4. Blood Sample Collection: The test usually requires a blood sample. The sample is collected by drawing blood from a vein in your arm, which is a standard procedure for blood tests.
    5. Consult with Your Healthcare Provider: Before undergoing the test, discuss any concerns or questions with your healthcare provider. They will explain the purpose of the test and how the results will be used to guide your treatment

    Related products